Current research and development into new antibacterial agents

摘要

In recent years, there has been an increased need for new antibacterial chemotherapy, as the emergence of bacterial resistance now poses a significant clinical problem. More and more bacteria are becoming resistant to conventional antibacterial chemotherapy, for example, meticillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE).